TY - JOUR
T1 - Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines
AU - Zanazzi, Claudia
AU - Hersmus, Remko
AU - Veltman, Imke M
AU - Gillis, Ad J M
AU - van Drunen, Ellen
AU - Beverloo, H Berna
AU - Hegmans, Joost P J J
AU - Verweij, Marielle
AU - Lambrecht, Bart N
AU - Oosterhuis, J Wolter
AU - Looijenga, Leendert H J
N1 - Copyright (c) 2007 Wiley-Liss, Inc.
PY - 2007/10
Y1 - 2007/10
N2 - Malignant mesothelioma (MM) is an asbestos-induced tumor that acquires aneuploid DNA content during the tumorigenic process. We used instable MM cell lines as an in vitro model to study the impact of DNA copy-number changes on gene expression profiling, in the course of their chromosomal redistribution process. Two MM cell lines, PMR-MM2 (early passages of in vitro culture) and PMR-MM7 (both early and late passages of in vitro culture), were cytogenetically characterized. Genomic gains and losses were precisely defined using microarray-based comparative genomic hybridization (array-CGH), and minimal overlapping analysis led to the identification of the common unbalanced genomic regions. Using the U133Plus 2.0 Affymetrix gene chip array, we analyzed PMR-MM7 early and late passages for genome-wide gene expression, and correlated the differentially expressed genes with copy-number changes. The presence of a high number of genetic imbalances occurring from early to late culture steps reflected the tendency of MM cells toward genomic instability. The selection of specific chromosomal abnormalities observed during subsequent cultures demonstrated the spontaneous evolution of the cancer cells in an in vitro environment. MM cell lines were characterized by copy-number changes associated with the TP53 apoptotic pathway already present at the first steps of in vitro culture. Prolonged culture led to acquisition of additional chromosomal copy-number changes associated with dysregulation of genes involved in cell adhesion, regulation of mitotic cell cycle, signal transduction, carbohydrate metabolism, motor activity, glycosaminoglycan biosynthesis, protein binding activity, lipid transport, ATP synthesis, and methyltransferase activity.
AB - Malignant mesothelioma (MM) is an asbestos-induced tumor that acquires aneuploid DNA content during the tumorigenic process. We used instable MM cell lines as an in vitro model to study the impact of DNA copy-number changes on gene expression profiling, in the course of their chromosomal redistribution process. Two MM cell lines, PMR-MM2 (early passages of in vitro culture) and PMR-MM7 (both early and late passages of in vitro culture), were cytogenetically characterized. Genomic gains and losses were precisely defined using microarray-based comparative genomic hybridization (array-CGH), and minimal overlapping analysis led to the identification of the common unbalanced genomic regions. Using the U133Plus 2.0 Affymetrix gene chip array, we analyzed PMR-MM7 early and late passages for genome-wide gene expression, and correlated the differentially expressed genes with copy-number changes. The presence of a high number of genetic imbalances occurring from early to late culture steps reflected the tendency of MM cells toward genomic instability. The selection of specific chromosomal abnormalities observed during subsequent cultures demonstrated the spontaneous evolution of the cancer cells in an in vitro environment. MM cell lines were characterized by copy-number changes associated with the TP53 apoptotic pathway already present at the first steps of in vitro culture. Prolonged culture led to acquisition of additional chromosomal copy-number changes associated with dysregulation of genes involved in cell adhesion, regulation of mitotic cell cycle, signal transduction, carbohydrate metabolism, motor activity, glycosaminoglycan biosynthesis, protein binding activity, lipid transport, ATP synthesis, and methyltransferase activity.
KW - Biomarkers, Tumor/genetics
KW - Blotting, Western
KW - Chromosome Aberrations
KW - Chromosome Mapping
KW - Chromosomes, Human/genetics
KW - Gene Dosage/genetics
KW - Gene Expression Profiling/methods
KW - Genome, Human/genetics
KW - Humans
KW - In Situ Hybridization, Fluorescence
KW - Mesothelioma/genetics
KW - Nucleic Acid Hybridization
KW - Oligonucleotide Array Sequence Analysis/methods
KW - Spectral Karyotyping
KW - Tumor Suppressor Protein p53/genetics
U2 - 10.1002/gcc.20475
DO - 10.1002/gcc.20475
M3 - Article
C2 - 17620293
SN - 1045-2257
VL - 46
SP - 895
EP - 908
JO - Genes Chromosomes and Cancer
JF - Genes Chromosomes and Cancer
IS - 10
ER -